Variant ID: 9-27135831-C-T

NM_000459.3(TEK):c.53-21998C>T

This variant was identified in 2 publications




Publications:


Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.

Plos One
I Makhoul, VK Todorova, ER Siegel, SW Erickson, I Dhakal, VR Raj, JY Lee, MS Orloff, RJ Griffin, RS Henry-Tillman, S Klimberg, LF Hutchins, SA Kadlubar
Publication Date: 2017

Variant appearance in text: rs7042119
PubMed Link: 28045923
PubMed Central Link
Variant Present in the following documents:
  • pone.0168550.s011.xlsx
  • pone.0168550.s006.xlsx
  • pone.0168550.s007.xlsx
  • pone.0168550.s004.xlsx
  • pone.0168550.s009.xlsx
  • pone.0168550.s005.xlsx
  • pone.0168550.s003.xlsx
View BVdb publication page



Angiogenesis genes, dietary oxidative balance and breast cancer risk and progression: the Breast Cancer Health Disparities Study.

International Journal Of Cancer
ML Slattery, EM John, G Torres-Mejia, A Lundgreen, JP Lewinger, MC Stern, L Hines, KB Baumgartner, AR Giuliano, RK Wolff
Publication Date: 2014-02-01

Variant appearance in text: rs7042119
PubMed Link: 23832257
PubMed Central Link
Variant Present in the following documents:
  • Main text
View BVdb publication page



Alternative transcript annotations:

Transcript cDNA Protein Consequence Exon Intron
ENST00000380036.4 c.53-21998C>T - intron_variant - 1/22
ENST00000406359.4 c.53-21998C>T - intron_variant - 1/21
ENST00000519080.1 c.52+26191C>T - intron_variant - 1/9
ENST00000519097.1 c.52+26191C>T - intron_variant - 1/20
NM_000459.4 c.53-21998C>T - intron_variant - 1/22
NM_001290077.1 c.53-21998C>T - intron_variant - 1/21
NM_001290078.1 c.52+26191C>T - intron_variant - 1/20